Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained‐release oral drug delivery systems for poorly water‐soluble drugs II. In‐vivo evaluation

Objectives  Lipid‐based liquid crystals formed from phytantriol (PHY) and glyceryl monooleate (GMO) retain their cubic‐phase structure on dilution in physiologically relevant simulated gastrointestinal media, suggesting their potential application as sustained‐release drug‐delivery systems for poorly water‐soluble drugs. In this study the potential of PHY and GMO to serve as sustained‐release lipid vehicles for a model poorly‐water‐soluble drug, cinnarizine, was assessed and compared to that of an aqueous suspension formulation.

[1]  Pharmaceutical Press.  Handbook of Pharmaceutical Excipients , 2012 .

[2]  I. Larson,et al.  Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained‐release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically‐relevant media , 2010 .

[3]  T. Hanley,et al.  Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs. , 2009, International journal of pharmaceutics.

[4]  B. Boyd,et al.  A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats. , 2007, International journal of pharmaceutics.

[5]  Clive G. Wilson,et al.  Low Dose Lipid Formulations: Effects on Gastric Emptying and Biliary Secretion , 2007, Pharmaceutical Research.

[6]  C. Porter,et al.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.

[7]  Colin W Pouton,et al.  Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  B. Boyd,et al.  A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[9]  A. Paradkar,et al.  Effect of drug solubility and different excipients on floating behaviour and release from glyceryl monooleate matrices. , 2004, International journal of pharmaceutics.

[10]  B. Boyd,et al.  Drug Solubilization Behavior During in Vitro Digestion of Suspension Formulations of Poorly Water-Soluble Drugs in Triglyceride Lipids , 2004, Pharmaceutical Research.

[11]  Ben J. Boyd,et al.  Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations , 2004, Pharmaceutical Research.

[12]  T. Landh,et al.  Phase behavior of the phytantriol/water system , 2003 .

[13]  T. Nylander,et al.  Effect of lipase on monoolein-based cubic phase dispersion (cubosomes) and vesicles , 2002 .

[14]  Allan Svendsen,et al.  Lipase action on a monoolein/sodium oleate aqueous cubic liquid crystalline phase—a NMR and X-ray diffraction study , 2002 .

[15]  Christopher J H Porter,et al.  Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products , 2002, The Journal of pharmacy and pharmacology.

[16]  C. Porter,et al.  Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. , 2001, Journal of pharmaceutical and biomedical analysis.

[17]  D M Chilukuri,et al.  Cubic phase gels as drug delivery systems. , 2001, Advanced drug delivery reviews.

[18]  Calum J. Drummond,et al.  Surfactant self-assembly objects as novel drug delivery vehicles , 1999 .

[19]  V. Stella,et al.  A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs. , 1999, Journal of pharmaceutical sciences.

[20]  V. Stella,et al.  A novel prodrug approach for tertiary amines. 2. Physicochemical and in vitro enzymatic evaluation of selected N-phosphonooxymethyl prodrugs. , 1999, Journal of pharmaceutical sciences.

[21]  D. Attwood,et al.  The release of drugs from monoglyceride-water liquid crystalline phases , 1994 .

[22]  T. Nagai,et al.  Enhancement of the oral bioavailability of cinnarizine in oleic acid in beagle dogs. , 1987, Journal of pharmaceutical sciences.

[23]  T. Nagai,et al.  Kinetics of degradation of cinnarizine in aqueous solution. , 1985, Chemical & pharmaceutical bulletin.

[24]  K. Kelly,et al.  Gastric emptying of liquids and solids: roles of proximal and distal stomach. , 1980, The American journal of physiology.

[25]  D. Hollander,et al.  Mechanism and Site of Small Intestinal Absorption of α-Tocopherol in the Rat , 1975 .

[26]  J. Baxter.  Absorption of chlorophyll phytol in normal man and in patients with Refsum's disease. , 1968, Journal of lipid research.

[27]  J. N. Hunt,et al.  A relation between the chain length of fatty acids and the slowing of gastric emptying , 1968, The Journal of physiology.

[28]  D. Steinberg,et al.  Absorption of phytol from dietary chlorophyll in the rat. , 1967, Journal of lipid research.

[29]  J. Avigan,et al.  Absorption and metabolism of uniformly 14C-labeled phytol and phytanic acid by the intestine of the rat studied with thoracic duct cannulation. , 1967, Biochimica et biophysica acta.

[30]  A. Nilsson,et al.  Hydrolysis of the cubic liquid-crystalline phase of glyceryl monooleate by human pancreatic lipases , 2002 .

[31]  D. Small,et al.  Lipid digestion and absorption. , 1983, Annual review of physiology.

[32]  Leon Shargel,et al.  Applied biopharmaceutics and pharmacokinetics , 1980 .